Trial intelligence / Profile preview

MOVIPREP vs CitraFleet for Polyp Detection

NCT01689792Phase 4Completed

Sponsor
Norgine
Start
Nov 2011
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of macrogol in colorectal cancer (CRC), sponsored by Norgine. Started Nov 2011; status: completed.

02

Drugs

macrogol
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01689792.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01689792.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call